Insmed stockINSM
Insmed trades at $108.76, 48.9% below its 52-week high (Dec 2, 2025). The price is below its 50- and 200-day averages, a downtrend. −37.5% year to date, −41.8% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 25, 2027.
Ratings, candles, signals and the screener for INSM — after you log in
Open the terminalFrequently asked questions about Insmed
What is the Insmed stock price?
At the close on Nov 5, 2026: $108.76 (−1.13% on the day). 52-week high: $212.75 on Dec 2, 2025. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Insmed report earnings?
The next quarterly report is on Feb 25, 2027. Last quarter, earnings per share changed +74% year over year, revenue +268%.
Does Insmed pay dividends?
No, Insmed does not pay dividends.
Where does Insmed trade and how to buy it?
Ticker INSM, exchange Nasdaq. You can buy it through a broker with access to US exchanges.
Should I buy Insmed now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for INSM are in the terminal after you log in.